Our previous studies have shown that KD can significantly inhibit the levels of serum leptin, free fatty acids, tumor necrosis factor (TNF)-α and plasminogen activator inhibitor-1, and increase the expression of serum adiponectin in rats with metabolic syndrome (Guangjuan et al., 2014). Here, TNF is linked to metabolic syndrome.